SAPS-CSTI-Générique21 - Science avec et pour la société – Culture scientifique, technique et industrielle - AAPG2021 2024

Ambition Dialogue REsearch Science Society – CNRS Ile-de-France Villejuif – ADRESS 2021 CNRSIdFVillejuif

Submission summary

The "ADDRESS CNRSIdFVillejuif" project is led by the CNRS Ile-de-France Villejuif. It aims to implement mediation and scientific promotion actions around research projects managed by the delegation within the framework ANR's 2021 generic calls for projects. The actions taken within the framework of this project will be deployed throughout the CNRS Ile-de-France Villejuif district and its institutional partners, and meet several objectives: to make science accessible and attractive, to bring science and citizens, encourage scientific careers.

In this regard, we are considering several scientific mediation actions:
• conferences within the framework of the national scientific mediation system of the CNRS « Échappées inattendues »,
• editorial content (podcasts and digital comics) for distribution on the blog, the national and regional digital channels of the CNRS, CNRS Le Journal
• photo and video reports for distribution on the national and regional digital channels of the CNRS, CNRS Images platform, CNRS Le Journal and made available to ANR project teams, the laboratory and its joint supervision,
• territorial actions (film-debates, photo exhibitions in CCSTIs, the Pint of Science festival, « Visites Insolites » in CNRS laboratories)

Project coordination

Miryam Morand (CNRS Délégation Ile-de-France Villejuif)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

CNRS Délégation Ile-de-France Villejuif

Help of the ANR 57,500 euros
Beginning and duration of the scientific project: - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter